TITULO:
Brazil’s Family Health Strategy: factors associated with programme uptake and coverage expansion over 15 years (1998-2012).AUTORES: ANDRADE, MONICA VIEGAS; COELHO, AUGUSTO QUARESMA ; XAVIER NETO, MAURO ; CARVALHO, LUCAS RESENDE DE ; ATUN, RIFAT ; CASTRO, MARCIA C.
LOCAL DA PUBLICAÇÃO:
(Português do Brasil) Health Policy and Planning, v. 33, p. 368-380, 2018.ANO: 2018Outros resutlados:
Filtrar por Ano:
Anos 2026 2025 2024 2020 2019 2018 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001
TITLE:
(Português do Brasil) Economic burden of Chagas disease in Latin American countries: a population-based cost-of-illness analysis from the RAISE studyAUTHORS: Sorry, this entry is only available in Português do Brasil .
HOST:
The Lancet Regional Health – AmericasYEAR:
2026
TITLE:
(Português do Brasil) THE PHARMACEUTICAL MARKET: a transdisciplinary description of concepts and their implicationsAUTHORS: Sorry, this entry is only available in Português do Brasil .
HOST:
Expert Review of Pharmacoeconomics & Outcomes ResearchYEAR:
2026
TITLE:
(Português do Brasil) The Market for Monoclonal Antibodies: Trends, Challenges, and OpportunitiesAUTHORS: Sorry, this entry is only available in Português do Brasil .
HOST:
(Português do Brasil) BioDrugs (Springer Nature)YEAR:
2026
TITLE:
(Português do Brasil) Economic burden of malaria in the Brazilian Amazon from a societal perspectiveAUTHORS: Sorry, this entry is only available in Português do Brasil .
HOST:
(Português do Brasil) PLOS Global Public HealthYEAR:
2026
TITLE:
(Português do Brasil) ACC.25: Custo econômico da doença de Chagas no Brasil: um estudo nacional de custo da doençaAUTHORS: Sorry, this entry is only available in Português do Brasil .
HOST:
(Português do Brasil) The Lancet Regional Health AmericasYEAR:
2025
TITLE:
(Português do Brasil) Assessing concentration in the monoclonal antibody innovation market: A patent-based studyAUTHORS: Sorry, this entry is only available in Português do Brasil .
HOST:
(Português do Brasil) Revista PlosOneYEAR:
2025